News Articles Tagged: Sarcoma Treatment

ZSTK474: Precision Targeting of the PI3K Pathway for Improved Sarcoma Treatment

Explore the scientific evidence behind ZSTK474's effectiveness against sarcomas. Understand how this PI3K inhibitor offers a more precise approach to cancer therapy.

Precision in Oncology: Tazemetostat's Impact on EZH2-Driven Cancers

Explore how Tazemetostat, a selective EZH2 inhibitor, is revolutionizing treatment for epithelioid sarcoma and follicular lymphoma by targeting specific genetic alterations.